2021 Endowment Fund Grants: successful grant recipients

Thanks to the generosity of donors to the Foundation’s Permanent Endowment Fund, twenty-four new ground-breaking Peter Mac cancer research projects will be established. In total, $1.3m in seed funding was awarded through the Foundation's 2021 Endowment Fund Grants program to help kick-start some of Peter Mac's most exciting new cancer research initiatives.

Selected through a rigorous peer review process, this year’s innovative cancer research projects have the potential to lead to the discovery of new ideas and advance knowledge in cancer research and care.

The Foundation is very grateful to the generous individuals who make these annual Grants possible by donating to the Foundation's Endowment Fund.

Recipients of this year's Grants are:


Project Title


Dr Kirsty Carey

Identifying cellular targets of novel therapeutics inhibiting messenger RNA export in cancer


Dr Keefe Chan

Understanding “sleeping cells” to develop better treatments for ovarian cancer


Ms Elisa Cops

The Inherited Cancer Connect (ICCon) Partnership Pathogenic Variant Database: A Unique National-level Initiative to Enable Familial Cancer Research


Prof Riccardo Dolcetti

New multipronged strategy to enhance the immunotherapeutic treatment of brain metastasis.


Dr Julia Dubowitz

The impact of perioperative administration of seasonal influenza vaccine on recurrence rates of solid tumours


Dr Mohamed Fareh

A novel RNA editing technology as treatment for virus-driven tumours


Dr Heidi Fettke

Molecular profiling of circulating tumour DNA from advanced prostate cancer patients receiving Lutetium PSMA radionuclide therapy


Dr Luc Furic

Identifying α-helical stapled peptides that can bind to STEAP1 for theranostic application against prostate cancer


Dr David Goode

Building a statistical framework for studying changes to the tumour immune microenvironment


Dr Sue Haupt

Discovering new explanations of cancer sec-disparities to guide precision medicine


Dr Tanjina Kader

Understanding the role of Natural Killer cells in suppressing breast cancer development.


Dr James Korte

Sitting up for Radiotherapy: design and evaluation of an upright patient positioning system


Dr Erin Laing

Development of a neuroendocrine tumour-specific nutrition-risk screening tool to identify patients with neuroendocrine tumours requiring nutrition intervention and education


Dr Emily Lelliott

Using genetic screens to unleash the cancer-fighting potential of the immune system.


Dr Fiona Lynch

Acceptability and feasibility of Managing Cancer and Living Meaningfully (CALM) in people with non-small celi lung cancer (NSCLC) treated with novel therapies


Ms Celia Marston

Feasibility of the CSNAT-DC intervention to optimise hospital discharge in advanced cancer: a single-arm, open label study


Dr Simone Nüessing

Improving adoptive T cell therapy through development of a novel genetic screen for regulators of T cell receptor stability


A/Prof Jane Oliaro

A new mouse model to test a novel combination CAR-T cell therapy for breast cancer


A/Prof Belinda Parker

Development of preclinical models for immunotherapeutic targeting of METastasis (Imet).


Dr Angela Pizzolla

Defining the targets of the T cell immune response in human papillomavirus related oropharyngeal cancers


Mr Timothy Semple

Evaluation of Long Road Sequencing in Single Cell Genomics


Dr Joseph Sia

Investigating the immunological impact of radiosurgery for brain metastases from breast cancer


Dr Clare Slaney

Corona CAR providing a road map to cancer treatment


Dr Joe Zhu

Switching CAR-T cell suppression to activation in cold tumours


To view the 2019 Peter Mac cancer research projects that were established through the Foundation's Endowment Fund click here.